Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2774156 | Endocrinología y Nutrición | 2011 | 10 Pages |
Abstract
The BRAFT1799A mutation is associated to age over 60 and a tumor size of 1Â cm or greater, but not to other clinicopathological characteristics, tumor recurrence or PTC persistence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Marisa Cañadas Garre, MartÃn López de la Torre Casares, Patricia Becerra Massare, Miguel Ángel López Nevot, Jesús Villar Del Moral, Nuria Muñoz Pérez, Ricardo VÃlchez Joya, Rosa Montes RamÃrez, José Manuel Llamas Elvira,